Literature DB >> 15886802

Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation.

Elizabeth Sconce1, Tayyaba Khan, Jennifer Mason, Faye Noble, Hilary Wynne, Farhad Kamali.   

Abstract

Evidence suggests that alterations in the dietary intake of vitamin K can affect anticoagulation response to warfarin. It is possible that a low and erratic intake of dietary vitamin K is at least partly responsible for the variable response to warfarin in patients with unstable control of anticoagulation. Twenty-six patients with unstable and twenty-six with stable control of anticoagulation completed dietary records of all foods and drinks consumed on a daily basis for two consecutive weeks. The mean daily intake of vitamin K in unstable patients was considerably lower than that for stable patients during the study period (29+/-17 microg v . 76+/-40 microg). The logarithm of vitamin K intake was consistently and significantly lower in the unstable patients than the stable patients over the two week period (5.9+/-0.4 microg v. 6.9+/-0.5 microg; p<0.001; 95% CI: 0.7-1.2). Changes in vitamin K intake between weeks 1 and 2 of the study were negatively correlated with changes in International Normalised Ratio (INR) amongst the unstable patients, however this failed to reach significance (r=-0.25; p=0.22). Daily supplementation with oral vitamin K in unstable patients could lead to a more stable anticoagulation response to warfarin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886802     DOI: 10.1160/TH04-12-0773

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  17 in total

Review 1.  Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure.

Authors:  Andrea Lee; Mark Crowther
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

Review 2.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Venous thromboembolic disease.

Authors:  Michael B Streiff; Paula L Bockenstedt; Spero R Cataland; Carolyn Chesney; Charles Eby; John Fanikos; Patrick F Fogarty; Shuwei Gao; Julio Garcia-Aguilar; Samuel Z Goldhaber; Hani Hassoun; Paul Hendrie; Bjorn Holmstrom; Kimberly A Jones; Nicole Kuderer; Jason T Lee; Michael M Millenson; Anne T Neff; Thomas L Ortel; Judy L Smith; Gary C Yee; Anaadriana Zakarija
Journal:  J Natl Compr Canc Netw       Date:  2011-07-01       Impact factor: 11.908

4.  Multivariate analysis of the relation between diet and warfarin dose.

Authors:  Morten Arendt Rasmussen; Jane Skov; Else-Marie Bladbjerg; Johannes J Sidelmann; Marianne Vamosi; Jørgen Jespersen
Journal:  Eur J Clin Pharmacol       Date:  2011-09-21       Impact factor: 2.953

5.  High intra- and inter-individual variability of plasma vitamin K concentrations in patients with atrial fibrillation under warfarin therapy.

Authors:  Y-E Kim; H I Woo; Y K On; J S Kim; S-Y Lee
Journal:  Eur J Clin Nutr       Date:  2015-04-01       Impact factor: 4.016

6.  New educational approach for patients on warfarin improves knowledge and therapy control.

Authors:  Alenka Mavri; Nina Ostasevski Fernandez; Anja Kramaric; Katarina Kosmelj
Journal:  Wien Klin Wochenschr       Date:  2015-04-01       Impact factor: 1.704

7.  Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trial.

Authors:  Alma Rut Oskarsdóttir; Brynja R Gudmundsdottir; Olafur S Indridason; Sigrun H Lund; David O Arnar; Einar S Bjornsson; Magnus K Magnusson; Hulda M Jensdottir; Brynjar Vidarsson; Charles W Francis; Pall T Onundarson
Journal:  J Thromb Thrombolysis       Date:  2017-05       Impact factor: 2.300

8.  Vitamin K1 supplementation to improve the stability of anticoagulation therapy with vitamin K antagonists: a dose-finding study.

Authors:  Edward P A Gebuis; Frits R Rosendaal; Erik van Meegen; Felix J M van der Meer
Journal:  Haematologica       Date:  2010-12-29       Impact factor: 9.941

9.  Supplemental vitamin K improves the stability of anticoagulation in a patient with low tissue stores of vitamin K secondary to coeliac disease.

Authors:  Cassandra Emily Janeczko; Karen Sweeney; G Connaghan
Journal:  BMJ Case Rep       Date:  2009-05-17

Review 10.  Warfarin and vitamin K intake in the era of pharmacogenetics.

Authors:  Yael Lurie; Ronen Loebstein; Daniel Kurnik; Shlomo Almog; Hillel Halkin
Journal:  Br J Clin Pharmacol       Date:  2010-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.